Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET
From Fulcrum Therapeutics, Inc.
Via GlobeNewswire
Tickers FULC
News headline image
Cole West Closes on 38 Homesites in Northern Utah for New Community
From Cole West
Via GlobeNewswire
News headline image
Axe Compute Unveils Compute Reserve Dashboard, Giving Investors a Unified View of Its NASDAQ Stock and Operational Strategic Compute Reserve
From Axe Compute Inc
Via GlobeNewswire
Tickers AGPU
News headline image
Abacus Global Management to Participate in the 2026 Milken Institute Global Conference
From Abacus Global Management
Via GlobeNewswire
Tickers ABLLW ABX
News headline image
2027 Kia Telluride Adds Hybrid Option Rated at Up to 35 MPG
From Feature Impact
Via GlobeNewswire
News headline image
The Double D Foundation Announces Major Gift From Patriot Mobile
From Patriot Mobile
Via GlobeNewswire
News headline image
Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
Tickers AMRX
News headline image
ZJK Industrial Co., Ltd. Advances Localization Strategy in Vietnam to Strengthen Global Production Network
From ZJK Industrial Co., Ltd.
Via GlobeNewswire
Tickers ZJK
News headline image
Aptean introduces AI platform and AI agents for Business Central On-Premises Customers
From Aptean Inc.
Via GlobeNewswire
News headline image
MainStreet Bancshares, Inc. Announces First Quarter 2026 Results
From MainStreet Bancshares, Inc.
Via GlobeNewswire
Tickers MNSB MNSBP
News headline image
Atsena Therapeutics Receives Data Monitoring Committee Recommendation to Proceed with Pivotal Part C Cohort of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis
From Atsena Therapeutics
Via GlobeNewswire
News headline image
Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer
From Helus Pharma
Via GlobeNewswire
Tickers HELP
News headline image
Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX BMY
News headline image
Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV108, an Allosteric SARM1 inhibitor
From Tenvie Therapeutics, Inc.
Via GlobeNewswire
News headline image
LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdom
From LENZ Therapeutics, Inc.
Via GlobeNewswire
Tickers LENZ
News headline image
Mountain Warehouse Launches Composable Ecommerce Store with BigCommerce to Accelerate Innovation and Global Growth
From Commerce.com, Inc.
Via GlobeNewswire
Tickers CMRC
News headline image
AskBio's Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease
From AskBio Inc. (AskBio)
Via GlobeNewswire
News headline image
Boehringer Ingelheim expands investment in computational innovation with new AI Accelerator in UK’s Knowledge Quarter
From Boehringer Ingelheim Limited
Via GlobeNewswire
News headline image
Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks
From Kyverna Therapeutics, Inc.
Via GlobeNewswire
Tickers KYTX
News headline image
Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026
From Phathom Pharmaceuticals
Via GlobeNewswire
Tickers PHAT
News headline image
RedCloud to Enter Live Deployment Phase as Combined Turkey and Saudi Joint Ventures Represent Up to $80 Million Revenue
From RedCloud Holdings plc
Via GlobeNewswire
Tickers RCT
News headline image
NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference
From NewcelX Ltd.
Via GlobeNewswire
Tickers NCEL
News headline image
Nexera: KeepZone AI Enters into White Label Agreement to Develop its AI-Based Voice Communication Decision Support System
From Nexera Technologies Ltd
Via GlobeNewswire
Tickers NEXR NEXRW
News headline image
Biogen Enters into Agreement with TJ Biopharma for Felzartamab Assets in the Greater China Region
From Biogen Inc.
Via GlobeNewswire
Tickers BIIB
News headline image
Palvella Therapeutics to Present QTORIN™ Rapamycin Results from Phase 3 SELVA and Phase 2 TOIVA Studies at the International Society for the Study of Vascular Anomalies World Congress 2026
From Palvella Therapeutics Inc.
Via GlobeNewswire
Tickers PVLA
News headline image
Cronos Group Inc. to Hold 2026 First Quarter Earnings Conference Call on May 11, 2026
From Cronos Group Inc.
Via GlobeNewswire
Tickers CRON TSX:CRON
News headline image
Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors
From WW International Inc.
Via GlobeNewswire
Tickers WW
News headline image
Swvl Announces FY 2025 Results; Revenue Up 41% to $24.2 million; Net Income $1.3 million; NDR of 128%; GCC Revenue Up 122%
From Swvl Holdings Corp
Via GlobeNewswire
Tickers SWVL
News headline image
New Found Gold Announces $205M Finance Package
From New Found Gold Corp.
Via GlobeNewswire
Tickers TSX-V:NFG
News headline image
Clearmind Medicine Announced Positive Top-Line Safety Results: CMND-100 Proprietary Psychedelic Treatment Meets Primary Endpoint in AUD Trial
From Clearmind Medicine Inc.
Via GlobeNewswire
Tickers CMND
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.